Bavarian Nordic, GSK To Produce Imvamune For Smallpox Vaccine Stockpile

The companies will collaborate on manufacturing the modified vaccinia Ankara-Bavarian Nordic vaccine for any future HHS contracts. Under the deal, GSK will also market Imvamune in the Americas, Japan and parts of the EU.